Kay See Tan1, David J Libon, Katya Rascovsky, Murray Grossman, Sharon X Xie. 1. Departments of *Biostatistics and Epidemiology ‡Neurology, Perelman School of Medicine, University of Pennsylvania †Department of Neurology, Drexel University College of Medicine, Philadelphia, PA.
Abstract
OBJECTIVE: To examine how phenotype affects longitudinal decline on the Mini-Mental State Examination (MMSE) in patients with frontotemporal lobar degeneration (FTLD) and Alzheimer disease (AD). BACKGROUND: The MMSE is the most commonly administered assessment for dementia severity; however, the effects of phenotype on longitudinal MMSE performance in FTLD and AD have not been extensively studied. METHODS: Data from 185 patients diagnosed with AD (n=106) and 3 FTLD (n=79) phenotypes [behavioral variant frontotemporal dementia (bvFTD), nonfluent agrammatic variant of primary progressive aphasia (nfaPPA), and semantic variant PPA (svPPA)] were collected for up to 52 months since initial evaluation. RESULTS: Differential rates of decline were noted in that MMSE scores declined more precipitously for AD and svPPA compared with bvFTD and nfaPPA patients (P=0.001). The absolute 4-year MMSE decline given median baseline MMSE for bvFTD [14.67; 95% confidence interval (CI), 14.63-14.71] and nfaPPA (11.02; 95% CI, 10.98-11.06) were lower than svPPA (22.32; 95% CI, 22.29-22.34) or AD (22.24; 95% CI, 22.22-22.26). CONCLUSIONS: These data suggest that within-group AD and FTLD phenotypes present distinct patterns of longitudinal decline on the MMSE. MMSE may not be adequately sensitive to track disease progression in some phenotypes of FTLD.
OBJECTIVE: To examine how phenotype affects longitudinal decline on the Mini-Mental State Examination (MMSE) in patients with frontotemporal lobar degeneration (FTLD) and Alzheimer disease (AD). BACKGROUND: The MMSE is the most commonly administered assessment for dementia severity; however, the effects of phenotype on longitudinal MMSE performance in FTLD and AD have not been extensively studied. METHODS: Data from 185 patients diagnosed with AD (n=106) and 3 FTLD (n=79) phenotypes [behavioral variant frontotemporal dementia (bvFTD), nonfluent agrammatic variant of primary progressive aphasia (nfaPPA), and semantic variant PPA (svPPA)] were collected for up to 52 months since initial evaluation. RESULTS: Differential rates of decline were noted in that MMSE scores declined more precipitously for AD and svPPA compared with bvFTD and nfaPPA patients (P=0.001). The absolute 4-year MMSE decline given median baseline MMSE for bvFTD [14.67; 95% confidence interval (CI), 14.63-14.71] and nfaPPA (11.02; 95% CI, 10.98-11.06) were lower than svPPA (22.32; 95% CI, 22.29-22.34) or AD (22.24; 95% CI, 22.22-22.26). CONCLUSIONS: These data suggest that within-group AD and FTLD phenotypes present distinct patterns of longitudinal decline on the MMSE. MMSE may not be adequately sensitive to track disease progression in some phenotypes of FTLD.
Authors: Joel H Kramer; Jennifer Jurik; Sharon J Sha; Kate P Rankin; Howard J Rosen; Julene K Johnson; Bruce L Miller Journal: Cogn Behav Neurol Date: 2003-12 Impact factor: 1.600
Authors: Rosalinde E R Slot; Sietske A M Sikkes; Johannes Berkhof; Henry Brodaty; Rachel Buckley; Enrica Cavedo; Efthimios Dardiotis; Francoise Guillo-Benarous; Harald Hampel; Nicole A Kochan; Simone Lista; Tobias Luck; Paul Maruff; José Luis Molinuevo; Johannes Kornhuber; Barry Reisberg; Steffi G Riedel-Heller; Shannon L Risacher; Susanne Roehr; Perminder S Sachdev; Nikolaos Scarmeas; Philip Scheltens; Melanie B Shulman; Andrew J Saykin; Sander C J Verfaillie; Pieter Jelle Visser; Stephanie J B Vos; Michael Wagner; Steffen Wolfsgruber; Frank Jessen; Wiesje M van der Flier Journal: Alzheimers Dement Date: 2018-12-13 Impact factor: 21.566
Authors: Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert Journal: J Neural Transm (Vienna) Date: 2017-09-01 Impact factor: 3.575
Authors: Amir Nazem; Chris C Tang; Phoebe Spetsieris; Christian Dresel; Marc L Gordon; Janine Diehl-Schmid; Timo Grimmer; Igor Yakushev; Paul J Mattis; Yilong Ma; Vijay Dhawan; David Eidelberg Journal: Alzheimers Dement (Amst) Date: 2018-08-29
Authors: Gary Arendash; Haitham Abulaban; Susan Steen; Ross Andel; Yanhong Wang; Yun Bai; Rob Baranowski; Jon McGarity; Lyle Scritsmier; Xiaoyang Lin; Ning Shen; Ali Aljassabi; Yitong Li; Chuanhai Cao Journal: Medicines (Basel) Date: 2022-08-03
Authors: Catherine F Slattery; Jonathan A Beck; Lorna Harper; Gary Adamson; Zeinab Abdi; James Uphill; Tracy Campbell; Ron Druyeh; Colin J Mahoney; Jonathan D Rohrer; Janna Kenny; Jessica Lowe; Kelvin K Leung; Josephine Barnes; Shona L Clegg; Melanie Blair; Jennifer M Nicholas; Rita J Guerreiro; James B Rowe; Claudia Ponto; Inga Zerr; Hans Kretzschmar; Pierluigi Gambetti; Sebastian J Crutch; Jason D Warren; Martin N Rossor; Nick C Fox; John Collinge; Jonathan M Schott; Simon Mead Journal: Alzheimers Dement Date: 2014-08-23 Impact factor: 21.566